Showing items 1 - 6 of 6

Your selections:

Novel piperazine-1,2,3-triazole leads for the potential treatment of pancreatic cancer

- Sun, Jufeng, Baker, Jennifer R., Russell, Cecilia C., Pham, Hong N. T., Goldsmith, Chloe D., Cossar, Peter J., Sakoff, Jennette A., Scarlett, Christopher J., McCluskey, Adam

3,5-Bis(trifluoromethyl)phenylsulfonamides, a novel pancreatic cancer active lead. Investigation of the terminal aromatic moiety

- Sun, Jufeng, Ambrus, Joey I., Baker, Jennifer R., Russell, Cecilia C., Cossar, Peter J., Sakoff, Jennette A., Scarlett, Christopher J., McCluskey, Adam

Cytotoxic 1,2,3-Triazoles as Potential Leads Targeting the S100A2-p53 Complex: Synthesis and Cytotoxicity

- Sun, Jufeng, Baker, Jennifer R., Russell, Cecilia C., Cossar, Peter J., Ngoc Thuy Pham, Hong, Sakoff, Jennette A., Scarlett, Christopher J., McCluskey, Adam

Small molecule inhibitors targeting the S100A2-p53 complex for potential treatments of pancreatic cancer

- Sun, Jufeng

  • Creator: Sun, Jufeng
  • Resource Type: thesis
  • Date: 2021

Targeting the S100A2-p53 Interaction with a Series of 3,5-Bis(trifluoromethyl)benzene Sulfonamides: Synthesis and Cytotoxicity

- Sun, Jufeng, Ambrus, Joey I., Russell, Cecilia C., Baker, Jennifer R., Cossar, Peter J., Pirinen, Melanie J., Sakoff, Jennette A., Scarlett, Christopher J., McCluskey, Adam

Small molecule inhibitors in pancreatic cancer

- Sun, Jufeng, Russell, Cecilia C., Scarlett, Christopher J., McCluskey, Adam

  • 1
  • Disclaimer
  • Privacy
  • Copyright
  • Contact
  • Deposit